GlobeNewswire

AdColony Launches $5 Million Advanced Monetization Program for Publishers

Share

Growth initiative for mobile app publishers to adopt the latest in-app monetization technology

LOS ANGELES, May 03, 2019 (GLOBE NEWSWIRE) -- AdColony, the mobile performance marketplace, today announced the launch of a $5 million Advanced Monetization Program (AMP) -- a tailored set of incentives designed to encourage publishers to adopt the latest in-app monetization technologies through the advanced technology of AdColony’s SDK. AdColony believes so strongly in its product that in an effort to distribute the fund to developers, they are offering publishers in the AdColony marketplace 100 percent revenue share for 90 days, a 15 percent user acquisition credit, and up to 10 percent bonus on first position waterfall deals to those who participate.

“We are thrilled to announce the Advanced Monetization Program to help publishers both earn and grow with AdColony,” said Vikas Gulati, AdColony’s head of performance. ”Video ad monetization for mobile app developers has made huge leaps in the past few years and we believe strongly that there are still many developers who need to take advantage of it.”

“AMP is designed to support game developers with both monetization and user acquisition efforts, helping them take the leap with the most technologically advanced monetization solution on the market,” Gulati added.

AdColony not only has the technology to enable best-in-class mobile ad creative but is also integrated with advanced bidding solutions from Google, Fyber, MoPub and others that enable publishers to maximize revenue on a real-time, impression by impression basis.

"GSN Games has proudly partnered with AdColony for the past five years,” said Brian Truman, Executive Director, Head of Digital Ad Monetization at GSN Games. “We continue this relationship because AdColony provides the highest level of support and the best quality ad experience for our players. Ad monetization is complex and always changing and we’ve seen time and time again that AdColony is committed to being a strategic, forward-thinking technology partner that continues to overcome industry shifts and hurdles."

By combining its solution offerings with personalized account management teams, AdColony is able to constantly optimize supply and demand to maximize publisher results. Other SDKs in the marketplace fail to take advantage of the latest in-demand sources due to their lack of access to current or optimized mobile inventory. 

“When it comes to monetization, publishers like us look for ad networks that are easy to integrate and manage, while at the same time provide competitive fill rates and revenue figures,” said Nader Tfaili, Chief Business Officer of Numbase, publisher of the popular trivia app, Play & Win. “AdColony is a perfect fit for such criteria. Working with AdColony’s account managers and support team, we were able to smoothly operate and monetize our app and continuously optimize performance, helping us grow.”
           
Publishers with no prior relationship with AdColony as well as those who have worked with AdColony in the past are invited to participate in the Advanced Monetization Program. To qualify, publishers must:

  • Complete this form:
    https://www.adcolony.com/technology/sdk/sdk-2019q2/
  • Agree to the standard AdColony publisher terms of service
  • Sign the supplemental Incentive Agreement and submit by June 30, 2019
  • Place an app live on the AdColony marketplace by June 30, 2019. Only apps distributed on the Google Play or Apple App Stores will qualify for this promotion. Test apps do not qualify.

The launch of AdColony’s program creates more money for publishers to monetize their apps and the best opportunity for developers to break even on their app development. For more information about the Advanced Monetization Program, visit https://www.adcolony.com/amp.

About AdColony
AdColony is one of the largest mobile advertising platforms in the world with a reach of more than 1.5 billion users globally. Known for its unparalleled 3rd party verified viewability rates, exclusive Instant-Play™ and Aurora™ HD video technologies, rich media formats, global performance advertising business and programmatic marketplace, and extensive SDK footprint in the Top 1000 apps worldwide, they are passionate about helping brands connect with consumers at scale on the most important screen in their lives. A fully-owned subsidiary of Otello Corporation ASA, AdColony is a global organization with over 20 offices worldwide.

Media Contact:
Alexis Roberts
Blast PR for AdColony
805-886-8511 

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Kalmar to enhance STS crane capabilities at EUROGATE Tanger20.8.2019 10:00:00 CESTPress release

CARGOTEC CORPORATION, PRESS RELEASE, 20 AUGUST 2019 AT 11 AM (EEST) Kalmar, part of Cargotec, has concluded an agreement with long-term customer EUROGATE Tanger in Morocco to upgrade the capabilities of four ZPMC ship-to-shore (STS) cranes. The order was booked in Cargotec's 2019 Q3 order intake, and the project is scheduled to commence in Q1 of 2020 and be completed in Q2 2021. The EUROGATE Tanger (EGT) container terminal is conveniently located on the Strait of Gibraltar in Morocco, making it the ideal transhipment hub for the western Mediterranean, Africa, as well as North and South America. With a quay length of 812 m, a terminal area of 400,000 m² and a water depth of up to 18 m, the facility is well-equipped to handle the new generation of container ships. The terminal’s equipment fleet already includes several Kalmar machines, including rubber-tyred gantry cranes (RTGs). Kalmar will be responsible for the planning, engineering and execution of the entire project, which involves

Oboya får en viktig order i USA20.8.2019 09:31:00 CESTPressemelding

Oboya Horticulture Industries AB (publ) (”Oboya”) har genom sitt helägda dotterbolag Oboya Metal Qingdao Co. Ltd i Qingdao, Kina fått en order från befintlig kund i USA. Ordervärdet uppgår till ca 0,37 MUSD, motsvarande ca 3,59 MSEK. Ordern avser leverans av blomstervagnar och kommer att levereras från september och fram till oktober 2019. Ordervärdet uppgår till 0,37 MUSD, motsvarande ca 3,59 MSEK. Den befintliga kunden är ett av de ledande logistik-, transport- och serviceföretagen inom odlingsindustrin i Nordamerika. Blomstervagnarna kommer att användas för såväl effektiv transport som för exponering av växter eller blommor i butik. "Det är glädjande att det finns fortsatt efterfrågan på Oboyas produkter i USA, trots nuvarande handelskonflikt mellan Kina och USA. Vi kommer att fortsätta att etablera oss på marknaden och därigenom successivt öka våra marknadsandelar globalt på sikt”, säger Robert Wu, VD för Oboya Horticulture Industries AB. Erik Penser Bank AB är Oboyas Certified Adv

Oboya receives an important order in USA20.8.2019 09:31:00 CESTPress release

Oboya Horticulture Industries AB (publ) ("Oboya") has through its wholly owned subsidiary Oboya Metal Qingdao Co. Ltd. in Qingdao, China received an order from an existing customer in the United States. The order value amounted to approximately USD 0.37 million, corresponding to approximately SEK 3.59 million. The order concerns delivery of flower trolleys and will be delivered from September until October 2019. The order value amounts to USD 0.37 million, corresponding to approximately SEK 3.59 million. The existing customer is one of the leading logistics, transport and service companies in the cultivation industry in North America. The flower trolleys will be used for efficient transport as well as for the exposure of plants or flowers in stores. "It is gratifying that there is continued demand for Oboya's products in the US, despite the current trade conflict between China and the US. We will continue to establish ourselves in the market and thereby gradually increase our market sh

Conditions for sale of Riksbank certificates20.8.2019 09:30:00 CESTPress release

AUCTION DATE: AUG 20, 2019 START DATE: AUG 21, 2019 MATURITY DATE: AUG 28, 2019 NOMINAL AMOUNT: 414.0 BLN FIXED RATE: -0.25 % ALL MONETARY POLICY COUNTERPARTIES ARE INVITED TO SUBMIT BIDS TO THE RIKSBANK (08-6966970) BY 10.00 AM ON AUG 20, 2019, AT THE LATEST. CONFIRMATION OF BIDS TO E-MAIL: RBCERT@riksbank.se THE LOWEST ACCEPTED BID VOLUME IS SEK 1 MLN. THE HIGHEST ACCEPTED BID VOLUME IS SEK 414.0 BLN. RESULT OF AUCTION WILL BE PUBLISHED AT 10.15 (CET/CEST) ON AUG 20, 2019. COMPLETE TERMS AND CONDITIONS CAN BE RETRIEVED AT WWW.RIKSBANK.SE

Karolinska Development's portfolio company Forendo Pharma commences Phase 1b study of its drug candidate FOR-621920.8.2019 09:00:00 CESTPressemelding

STOCKHOLM – August 20, 2019. Karolinska Development (Nasdaq Stockholm: KDEV) announces today that its portfolio company Forendo Pharma has initiated dosing in a Phase 1b clinical study with the aim to demonstrate Proof of Mechanism for FOR-6219 – a drug candidate intended for the treatment of endometriosis. Endometriosis is a chronic condition that affects up to 10 per cent of women in reproductive age and causes repeated pain symptoms, infertility and impaired quality of life. Currently available treatments have limitations in efficacy or cause harmful side effects due to estrogen depletion. FOR-6219 is a HSD17B1 inhibitor aiming to reduce estrogen production locally in the endometriosis lesions. In the Phase 1b study, FOR-6219 will be administered to healthy premenopausal women to explore its effect on the endometrium by measuring changes in endometrial thickness and endometrial estrogen levels. In addition to these local effects, systemic hormone levels will be measured. The study w